Berlin Skyline

Cardiovascular Health in the Time of COVID-19

Springer Nature, in collaboration with the Max Delbrück Center for Molecular Medicine, the Berlin Institute of Health at Charité and Charité – Universitätsmedizin Berlin, presents a panel discussion entitled “Cardiovascular health and COVID-19”.

COVID-19, caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic that has affected the lives of the entire human population. The panel, composed of Berlin-based renowned experts in basic, translational and clinical science focused on cardiovascular disease and immunology, will discuss three key aspects:

How pre-existing cardiovascular condition is associated with worse outcomes and increased risk of death in patients with COVID-19, how COVID-19 itself can induce cardiovascular disease, such as venous thromboembolism, high blood pressure, acute coronary syndrome, myocardial injury, and arrhythmia, and how we can minimize all these risks by vaccination.

#COVID19, caused by a severe acute respiratory syndrome coronavirus 2 (#SARSCoV2), has become a global #pandemic that has affected the lives of the entire human population. The panel, composed of Berlin-based experts in basic, translational and clinical science focused on cardiovascular disease and immunology, discusses three key aspects:

How are pre-existing #cardiovascular conditions associated with worse outcomes and increased risk of death in patients with COVID-19? How can COVID-19 itself induce cardiovascular disease, such as venous thromboembolism, high blood pressure, acute coronary syndrome, myocardial injury, and arrhythmia? And how can we minimize all these risks by #vaccination?

Further information

Time

-

Program

Panelists

Professor Holger Gerhardt, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin Institute of Health (BIH) at Charité and DZHK (German Center for Cardiovascular Research) Partner Site Berlin
Professor Michael Potente, Berlin Institute of Health (BIH) at Charité and Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)
Professor Leif Erik Sander, Department of Infectious Diseases and Respiratory Medicine, Charité – Universitätsmedizin Berlin
Professor Birgit Sawitzki, Berlin Institute of Health (BIH) at Charité and Institute of Medical Immunology, Charité – Universitätsmedizin Berlin 
Dr. Emanuel Wyler, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC)

Moderation

Dr. Vesna Todorovic, Chief Editor, Nature Cardiovascular Research


Organizers

Springer Nature | BIH, MDC